These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 19501358

  • 1. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
    Aucella F, Maas R, Vigilante M, Tripepi G, Schwedhelm E, Margaglione M, Gesualdo L, Boeger R, Zoccali C.
    Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
    [Abstract] [Full Text] [Related]

  • 2. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M, Fleck C, Wolf G, Stein G.
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [Abstract] [Full Text] [Related]

  • 3. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE, Zawada AM, Martens-Lobenhoffer J, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM.
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
    Shafi T, Hostetter TH, Meyer TW, Hwang S, Hai X, Melamed ML, Banerjee T, Coresh J, Powe NR.
    Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
    [Abstract] [Full Text] [Related]

  • 6. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach.
    Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C.
    J Am Soc Nephrol; 2005 Aug; 16(8):2449-55. PubMed ID: 15944335
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G.
    Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
    [Abstract] [Full Text] [Related]

  • 9. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
    Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Kulkarni P, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.
    Respir Res; 2017 Jan 23; 18(1):25. PubMed ID: 28114935
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
    Tripepi G, Mattace Raso F, Sijbrands E, Seck MS, Maas R, Boger R, Witteman J, Rapisarda F, Malatino L, Mallamaci F, Zoccali C.
    Clin J Am Soc Nephrol; 2011 Jul 23; 6(7):1714-21. PubMed ID: 21642364
    [Abstract] [Full Text] [Related]

  • 12. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B, Maas R, Vossen CY, Schwedhelm E, Koenig W, Böger R, Rothenbacher D, Brenner H, Breitling LP.
    Clin Res Cardiol; 2013 Mar 23; 102(3):193-202. PubMed ID: 23073705
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease.
    Pilz S, Putz-Bankuti C, Meinitzer A, März W, Kienreich K, Stojakovic T, Pieber TR, Stauber RE.
    Amino Acids; 2015 Sep 23; 47(9):1817-26. PubMed ID: 25952253
    [Abstract] [Full Text] [Related]

  • 15. Symmetric dimethylarginine is an independent predictor of intradialytic hypotension.
    Mangoni AA, Hewitson CL, Woodman RJ, Whiting MJ, McAteer-Carr B, Barbara JA.
    Am J Hypertens; 2008 Aug 23; 21(8):955-9. PubMed ID: 18551101
    [Abstract] [Full Text] [Related]

  • 16. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG, Aasarød KI, Sagen E, Åsberg A.
    Clin Biochem; 2015 Jul 23; 48(10-11):646-51. PubMed ID: 25828044
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M, Afsar B, Siriopol D, Unal HU, Karaman M, Saglam M, Eyileten T, Gezer M, Verim S, Oguz Y, Vural A, Ortiz A, Johnson RJ, Covic A, Yilmaz MI.
    Int Urol Nephrol; 2016 Jul 23; 48(7):1129-36. PubMed ID: 27007614
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
    Mortensen KM, Itenov TS, Haase N, Müller RB, Ostrowski SR, Johansson PI, Olsen NV, Perner A, Søe-Jensen P, Bestle MH.
    Shock; 2016 Oct 23; 46(4):365-72. PubMed ID: 27206279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.